US pharmaceutical tariffs may not have an “immediate impact” on Singapore’s drugmakers, Deputy Prime Minister Gan Kim Yong has said, adding that the government is in talks with Washington to get more information on the latest levies.Gan, who is also minister for trade and industry, told reporters on Saturday that most pharmaceutical companies in Singapore had built capacity in the US or had plans to do so. That could allow them to be exempted from the coming US pharmaceutical tariffs, he said,...